Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Johann Leban
Johann Leban, Martinsried DE
| Patent application number | Description | Published |
|---|---|---|
| 20080241100 | PHARMACEUTICAL COMPOSITION COMPRISING A CYTOKINE - The present invention relates to a pharmaceutical composition comprising, (i) a cytokine and, (ii) a compound of the general formula (Ih) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof. Exemplary cytokines are selected from the following group of cytokine families, (i) the four α-helix bundle family, which consists of, (a) the IL-2 subfamily, (b) the interferon (IFN) subfamily and, (c) the IL-10 subfamily, (ii) the IL-1 family, (iii) the IL-17 family and, (iv) chemokines. | 10-02-2008 |
| 20110052532 | Pharmaceutical composition comprising a cytokine - The present invention relates to a pharmaceutical composition comprising, (i) a cytokine and, (ii) a compound of the general formula (Ih) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof. Exemplary cytokines are selected from the following group of cytokine families, (i) the four α-helix bundle family, which consists of, (a) the IL-2 subfamily, (b) the interferon (IFN) subfamily and, (c) the IL-10 subfamily, (ii) the IL-1 family, (iii) the IL-17 family and, (iv) chemokines. | 03-03-2011 |
Johann Leban, Planegg-Martinsried DE
| Patent application number | Description | Published |
|---|---|---|
| 20090176716 | INHIBITORS OF CANCER CELL, T-CELL AND KERATINOCYTE PROLIFERATION - The invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 07-09-2009 |
| 20090304632 | HETEROCYCLIC NF-kB INHIBITORS - The present invention relates to compounds of the general formula (Ihb) or pharmaceutically acceptable salts thereof with an acid or a base or a stereoisomer thereof for the prevention and/or treatment of a disease associated with increased cytokine release, | 12-10-2009 |
| 20100280081 | ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 11-04-2010 |
Johann Leban, Germering DE
| Patent application number | Description | Published |
|---|---|---|
| 20100004258 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (III): | 01-07-2010 |
| 20100048574 | NOVEL HETEROCYCLIC NF-kB INHIBITORS - The present invention relates to compounds of the general formula (II): | 02-25-2010 |
| 20100048583 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 02-25-2010 |
| 20100267717 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates in one embodiment to compounds of formula (Ih) and/or a pharmaceutically acceptable salt thereof with an acid or a base, and/or a pharmaceutically acceptable prodrug and/or a stereoisomer thereof, | 10-21-2010 |
Johann Leban, Planegg DE
| Patent application number | Description | Published |
|---|---|---|
| 20080261971 | Novel Heterocyclic Nf-Kb Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, (I) wherein R | 10-23-2008 |